The Trump Administration is changing federal cannabis policy.

On Thursday acting Attorney General Todd Blanche signed an order reclassifying medical marijuana from a Schedule I to a Schedule III drug.

That puts the drug in the same category as substances like ketamine and anabolic steroids.

Now, this doesn’t mean cannabis is legal nationwide, and people with convictions related to marijuana won’t see their charges dropped. But officials say it’ll allow for more research into cannabis for medical use.

For distributors in the 40 states that have medical marijuana systems already in place, it could mean tax benefits and less hoops to jump through when selling cannabis.

This reclassification does not impact recreational marijuana. But advocates say it could be a sign of bigger changes to come.

Guest:

Dr. Susan Ferguson, Director of the Addictions, Drug & Alcohol Institute at the University of Washington

Related links:

Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes

Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.

See omnystudio.com/listener for privacy information.

Marijuana research may reach new heights as Trump Administration reclassifies medical cannabis